Cara Therapeutics reported $8.09M in Sales Revenues for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acadia Pharmaceuticals ACAD:US $ 110M 20M
Aerie Pharmaceuticals AERI:US $ 18M 2M
Antares Pharma ATRS:US $ 32M 1M
Biodelivery Sciences International BDSI:US $ 36M 2M
Chugai Pharma 4519:JP Y 208400M 19704M
Depomed DEPO:US $ 34.56M 13.95M
Endo International Ordinary Shares ENDP:US $ 634.86M 52.73M
Halozyme Therapeutics HALO:US $ 55.22M 29.87M
Horizon Pharma HZNP:US $ 636.43M 173.65M
JAZZ PHA JAZZ:US $ 600.89M 38.45M
Johnson & Johnson JNJ:US $ 21082M 2746M
Neurocrine Biosciences NBIX:US $ 302M 65M
Pacira Pharmaceuticals PCRX:US $ 75.5M 30.18M
Pfizer PFE:US $ 11801M 227M
Redhill Biopharma RDHL:US $ 20.94M 0.04M
Teva Pharmaceutical Industries TEVA:US $ 3978M 108M
Vanda Pharmaceuticals VNDA:US $ 62.21M 4.21M